Leukemia - Table of Contents alert Volume 26 Issue 1

TABLE OF CONTENTS Volume 26, Issue 1 (January 2012) In this issue Spotlight Reviews Review Editorial Original Articles Letters to the Editor Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Nature Immunology presents a webcast series on Current Controversies Webcasts now available free on demand on the following topics: Lineage Differentiation HIV Vaccines Human Immunology Sponsored by:     Spotlight Reviews Top SPOTLIGHT ON miRNA IN HEMATOPOIESIS MicroRNAs in acute leukemia: from biological players to clinical contributors D Schotte, R Pieters and M L Den Boer Leukemia 2012 26: 1-12; advance online publication, June 24, 2011; 10.1038/leu.2011.151 Abstract | Full Text Deregulation of microRNAs in myelodysplastic syndrome G W Rhyasen and D T Starczynowski Leukemia 2012 26: 13-22; advance online publication, August 19, 2011; 10.1038/leu.2011.221 Abstract | Full Text SPOTLIGHT ON STEM CELL HOMING AND MOBILISATION Mobilization of stem and progenitor cells in cardiovascular diseases W Wojakowski, U Landmesser, R Bachowski, T Jadczyk and M Tendera Leukemia 2012 26: 23-33; advance online publication, July 26, 2011; 10.1038/leu.2011.184 Abstract | Full Text Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4 M P Rettig, G Ansstas and J F DiPersio Leukemia 2012 26: 34-53; advance online publication, September 2, 2011; 10.1038/leu.2011.197 Abstract | Full Text The vascular niche: home for normal and malignant hematopoietic stem cells P L Doan and J P Chute Leukemia 2012 26: 54-62; advance online publication, September 2, 2011; 10.1038/leu.2011.236 Abstract | Full Text A novel perspective on stem cell homing and mobilization: review on bioactive lipids as potent chemoattractants and cationic peptides as underappreciated modulators of responsiveness to SDF-1 gradients M Z Ratajczak, C H Kim, A Abdel-Latif, G Schneider, M Kucia, A J Morris, M J Laughlin and J Ratajczak Leukemia 2012 26: 63-72; advance online publication, September 2, 2011; 10.1038/leu.2011.242 Abstract | Full Text Review Top Treatment strategies in relapsed and refractory multiple myeloma: a focus on drug sequencing and ‘retreatment’ approaches in the era of novel agents B Mohty, J El-Cheikh, I Yakoub-Agha, H Avet-Loiseau, P Moreau and M Mohty Leukemia 2012 26: 73-85; advance online publication, October 25, 2011; 10.1038/leu.2011.310 Abstract | Full Text Editorial Top Signal transduction pathways regulating hematopoietic stem cell biology: Introduction to a series of Spotlight Reviews T C Luis, N M-B Killmann and F J T Staal Leukemia 2012 26: 86-90; 10.1038/leu.2011.260 Full Text Original Articles Top MOLECULAR TARGETS FOR THERAPY AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications C Grimaldi, F Chiarini, G Tabellini, F Ricci, P L Tazzari, M Battistelli, E Falcieri, R Bortul, F Melchionda, I Iacobucci, P Pagliaro, G Martinelli, A Pession, J T Barata, J A McCubrey and A M Martelli Leukemia 2012 26: 91-100; advance online publication, October 4, 2011; 10.1038/leu.2011.269 Abstract | Full Text MYELODYSPLASIAS Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic Study of 277 patients M M Patnaik, C A Hanson, J M Hodnefield, T L Lasho, C M Finke, R A Knudson, R P Ketterling, A Pardanani and A Tefferi Leukemia 2012 26: 101-105; advance online publication, October 28, 2011; 10.1038/leu.2011.298 Abstract | Full Text STEM CELLS Conditioning for hematopoietic transplantation activates the complement cascade and induces a proteolytic environment in bone marrow: a novel role for bioactive lipids and soluble C5b-C9 as homing factors C H Kim, W Wu, M Wysoczynski, A Abdel-Latif, M Sunkara, A Morris, M Kucia, J Ratajczak and M Z Ratajczak Leukemia 2012 26: 106-116; advance online publication, July 19, 2011; 10.1038/leu.2011.185 Abstract | Full Text ONCOGENES, FUSION GENES AND TUMOR SUPPRESSOR GENES PIG7, transactivated by AML1, promotes apoptosis and differentiation of leukemia cells with AML1–ETO fusion gene J Liu, H Xing, Y Chen, L Wang, D Wang, Q Rao, K Tang, Z Tian, K He, M Wang and J Wang Leukemia 2012 26: 117-126; advance online publication, August 12, 2011; 10.1038/leu.2011.178 Abstract | Full Text DIFFERENTIATION Notch induces human T-cell receptor γδ+ thymocytes to differentiate along a parallel, highly proliferative and bipotent CD4 CD8 double-positive pathway S Van Coppernolle, S Vanhee, G Verstichel, S Snauwaert, A van der Spek, I Velghe, M Sinnesael, M H Heemskerk, T Taghon, G Leclercq, J Plum, A W Langerak, T Kerre and B Vandekerckhove Leukemia 2012 26: 127-138; advance online publication, November 4, 2011; 10.1038/leu.2011.324 Abstract | Full Text LYMPHOMA Monocytes and T cells cooperate to favor normal and follicular lymphoma B-cell growth: role of IL-15 and CD40L signaling G Epron, P Ame-Thomas, J Le Priol, C Pangault, J Dulong, T Lamy, T Fest and K Tarte Leukemia 2012 26: 139-148; advance online publication, July 26, 2011; 10.1038/leu.2011.179 Abstract | Full Text MYELOMA Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study S K Kumar, J H Lee, J J Lahuerta, G Morgan, P G Richardson, J Crowley, J Haessler, J Feather, A Hoering, P Moreau, X LeLeu, C Hulin, S K Klein, P Sonneveld, D Siegel, J Bladé, H Goldschmidt, S Jagannath, J S Miguel, R Orlowski, A Palumbo, O Sezer, S V Rajkumar, B G M Durie, on behalf of the International Myeloma Working Group and International Myeloma Working Group Leukemia 2012 26: 149-157; advance online publication, July 29, 2011; 10.1038/leu.2011.196 Abstract | Full Text Letters to the Editor Top Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experience H Avet-Loiseau, M Roussel, L Campion, X Leleu, G Marit, H Jardel, M Dib, O Decaux, T Lamy, M Tiab, P Cony-Makhoul, A Banos, G Lepeu, F Lifermann, M Macro, B Kolb, C Hulin, D Caillot, C Traulle, C Mathiot and B Royer Leukemia 2012 26: 158-159; advance online publication, July 29, 2011; 10.1038/leu.2011.176 Full Text The concurrent use of N- and C-terminal antibodies anti-nucleophosmin 1 in immunofluorescence experiments allows for precise assessment of its subcellular localisation in acute myeloid leukaemia patients A M Gruszka, C Martinelli, E Sparacio, P G Pelicci and A de Marco Leukemia 2012 26: 159-162; advance online publication, July 22, 2011; 10.1038/leu.2011.177 Full Text Limited clinical activity of nilotinib and sorafenib in FIP1L1-PDGFRA positive chronic eosinophilic leukemia with imatinib-resistant T674I mutation G Metzgeroth, P Erben, H Martin, S Mousset, M Teichmann, C Walz, T Klippstein, A Hochhaus, N C P Cross, W-K Hofmann and A Reiter Leukemia 2012 26: 162-164; advance online publication, August 5, 2011; 10.1038/leu.2011.181 Full Text New stem cell meeting on the Baltic Sea is launched M Z Ratajczak Leukemia 2012 26: 164-166; advance online publication, July 19, 2011; 10.1038/leu.2011.182 Full Text Clinical value of flow cytometric immunophenotypic analysis for minimal residual disease detection in autologous stem-cell products of follicular and mantle cell lymphomas H Kato, K Yamamoto, Y Oki, S Ine, H Taji, D Chihara, Y Kagami, M Seto and Y Morishima Leukemia 2012 26: 166-169; advance online publication, August 5, 2011; 10.1038/leu.2011.183 Full Text Coexistence of trisomies of chromosomes 12 and 19 in chronic lymphocytic leukemia occurs exclusively in the rare IgG-positive variant R Ibbotson, A Athanasiadou, L-A Sutton, Z Davis, A Gardiner, P Baliakas, R Gunnarsson, A Anagnostopoulos, G Juliusson, R Rosenquist, D Oscier and K Stamatopoulos Leukemia 2012 26: 170-172; advance online publication, July 26, 2011; 10.1038/leu.2011.186 Full Text Dynamics of the emergence of dasatinib and nilotinib resistance in imatinib-resistant CML patients F X Gruber, T Ernst, K Porkka, R A Engh, I Mikkola, J Maier, T Lange and A Hochhaus Leukemia 2012 26: 172-177; advance online publication, August 5, 2011; 10.1038/leu.2011.187 Full Text RUNX1–ETO deregulates the proliferation and growth factor responsiveness of human hematopoietic progenitor cells downstream of the myeloid transcription factor, MYCT1 K Liddiard, A K Burnett, R L Darley and A Tonks Leukemia 2012 26: 177-179; advance online publication, July 29, 2011; 10.1038/leu.2011.188 Full Text Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma D Martín-Pérez, P Vargiu, S Montes-Moreno, E A León, S M Rodríguez-Pinilla, L D Lisio, N Martínez, R Rodríguez, M Mollejo, J Castellvi, D G Pisano, M Sánchez-Beato and M A Piris Leukemia 2012 26: 180-183; advance online publication, July 26, 2011; 10.1038/leu.2011.189 Full Text Obesity and the risk of chronic myelogenous leukemia: is this another example of the neoplastic effects of increased body fat? M A Lichtman Leukemia 2012 26: 183-184; advance online publication, July 22, 2011; 10.1038/leu.2011.190 Full Text Array-based DNA methylation analysis in classical Hodgkin lymphoma reveals new insights into the mechanisms underlying silencing of B cell-specific genes O Ammerpohl, A Haake, S Pellissery, M Giefing, J Richter, B Balint, M Kulis, J Le, M Bibikova, H G Drexler, M Seifert, R Shaknovic, B Korn, R Küppers, J I Martín-Subero and R Siebert Leukemia 2012 26: 185-188; advance online publication, August 5, 2011; 10.1038/leu.2011.194 Full Text Circulating t(2;5)-positive cells can be detected in cord blood of healthy newborns C Laurent, C Lopez, C Desjobert, A Berrebi, C Damm-Welk, G Delsol, P Brousset and L Lamant Leukemia 2012 26: 188-190; advance online publication, August 12, 2011; 10.1038/leu.2011.209 Full Text Advertisement Don't miss these articles, recently published in Bone Marrow Transplantation: Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization New perspectives on the biology of acute GVHD   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Leukemia. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.